At the same time, critical questions regarding mechanisms, safety, and sustainability remain to be resolved
The short answer: GLP-1 medications don't directly increase or replace estrogen, progesterone, or other reproductive hormones
Therefore, treatment with GLP-1RAs shows favorable effects on anti-inflammation through the suppression of these proinflammatory cytokine and inflammatory signal pathways, as well as augmenting cholesterol efflux in the endothelium
As of 2024, approximately 11.6% of the U.S
Fairview Health Services, for example, only offers GLP-1 weight loss coverage to employees with a body mass index of 40 or higher